Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Inovio Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +7 vs. Q3 2024
- Shares held
- 13.3M
- +4.78M (+55.8%) vs. Q3 2024
- Total value
- $24.4M
- −$25.1M (−50.7%) vs. Q3 2024
- New holders
- 26
- 35 more added
- Sold out
- 19
- 14 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $36.1M |
| Q1 2026 | 99 | $54.6M |
| Q4 2025 | 101 | $57.5M |
| Q3 2025 | 99 | $48.4M |
| Q2 2025 | 103 | $20.7M |
| Q1 2025 | 108 | $22.2M |
| Q4 2024 | 105 | $24.4M |
| Q3 2024 | 98 | $49.5M |
| Q2 2024 | 96 | $65.1M |
| Q1 2024 | 89 | $56.4M |
| Q4 2023 | 116 | $25.7M |
| Q3 2023 | 127 | $21.6M |
| Q2 2023 | 135 | $32.1M |
| Q1 2023 | 177 | $99.8M |
| Q4 2022 | 186 | $198.5M |
| Q3 2022 | 183 | $200.0M |
| Q2 2022 | 185 | $196.2M |
| Q1 2022 | 201 | $330.4M |
| Q4 2021 | 209 | $428.9M |
| Q3 2021 | 213 | $554.9M |
| Q2 2021 | 211 | $683.1M |
| Q1 2021 | 219 | $693.7M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Inovio Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 654,115 | $1.20M | 0.45% | +654,115 | New |
| Stonepine Capital Management, LLC | 1,050,000 | $1.92M | 1.55% | +1,050,000 | New |
| Vanguard Group Inc | 1,673,588 | $3.06M | 0.00% | −124,372−6.9% | Reduced |
| BlackRock, Inc. | 1,908,511 | $3.49M | 0.00% | +22,916+1.2% | Added |
| Deep Track Capital, LP | 3,119,162 | $5.71M | 0.21% | +1,314,796+72.9% | Added |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −76,523−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −65,633−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −30,222−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −23,195−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −20,652−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −17,747−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −15,167−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −12,161−100.0% | Sold out |
| Pathstone Holdings, LLC | 0 | $0 | 0.00% | −10,266−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −1,733−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Valley National Advisers Inc | 0 | $0 | 0.00% | −636−100.0% | Sold out |
| City State Bank | 0 | $0 | 0.00% | −183−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Clear Point Advisors Inc. | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Tortoise Investment Management, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |